Immunome

IMNM • NASDAQ • Stock Fundamentals

Immunome is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Clay Siegall, with a market cap of $2.5B.

Market Cap$2.5B

Employees62.0

CEOClay Siegall

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Immunome

Immunome (IMNM) has a market capitalization of $2.5B and trades on NASDAQ.

Immunome has approximately 62 employees.